Indemnity Contract

An indemnity contract in insurance is an agreement between an insurer and an insured party, in which the insurer promises to reimburse the insured party for any losses or damages that they may incur. Under an indemnity contract, the insurer agrees to compensate the insured for any covered losses up to the limit of the policy, in exchange for a premium payment.

Example:

Let's say that John purchases an indemnity policy from an insurance company to protect his business from theft. The policy has a limit of $100,000 and requires a $5,000 deductible. If John's business is robbed and he sustains a loss of $80,000, he can file a claim with the insurer. Once the insurer verifies the claim, they will reimburse John for $75,000 ($80,000 minus the $5,000 deductible), up to the policy limit of $100,000.

Key features of an indemnity contract in insurance include:

• Compensation for covered losses: The insurer agrees to reimburse the insured for any losses that are covered by the policy.

• Limits and deductibles: The policy will have limits on the amount of coverage and may require a deductible, which is the amount that the insured must pay before the insurer will start reimbursing them.

• Premium payments: The insured party must pay a premium to the insurer in exchange for the coverage.

• Legal protection: The contract is legally binding and provides protection to both parties involved in the agreement.

• Coverage specifics: The policy will outline the specific types of losses or damages that are covered under the contract.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.